Nabriva Therapeutics plc reports

Company location: Dublin, Ireland
Fiscal year end: 31 December

Nabriva Therapeutics plc has filed 695 SEC EDGAR filings since 14 May 2015

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G
20-F
6-K

SEC filing history

Showing 526-550 of 695 matching filings.

Per page

25

Current page

22

4

4

Filing date: 29 Sep 2017
Reporting date: 27 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 26 Sep 2017
Reporting date: 22 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 26 Sep 2017
Reporting date: 22 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37558

8-K

Filing date: 20 Sep 2017
Reporting date: 19 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-219567

424B5

Filing date: 20 Sep 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 19 Sep 2017
Reporting date: 15 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 19 Sep 2017
Reporting date: 15 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 19 Sep 2017
Reporting date: 15 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 19 Sep 2017
Reporting date: 15 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 19 Sep 2017
Reporting date: 15 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 19 Sep 2017
Reporting date: 15 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-219567

424B5

Filing date: 19 Sep 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 18 Sep 2017
Reporting date: 18 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37558

8-K

Filing date: 18 Sep 2017
Reporting date: 18 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37558

8-K

Filing date: 15 Sep 2017
Reporting date: 15 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 14 Sep 2017
Reporting date: 12 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 05 Sep 2017
Reporting date: 31 Aug 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37558

8-K

Filing date: 31 Aug 2017
Reporting date: 31 Aug 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37558

8-K

Filing date: 21 Aug 2017
Reporting date: 17 Aug 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-37558

DEF 14A

Filing date: 18 Aug 2017
Reporting date: 15 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37558

8-K

Filing date: 11 Aug 2017
Reporting date: 09 Aug 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-219567

EFFECT filing

Filing date: 10 Aug 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 09 Aug 2017
Reporting date: 07 Aug 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 08 Aug 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37558

8-K

Filing date: 07 Aug 2017
Reporting date: 07 Aug 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .